dc.contributor.author |
Kalev, Maggie |
en |
dc.coverage.spatial |
Middlemore Hospital |
en |
dc.date.accessioned |
2018-10-08T22:42:34Z |
en |
dc.date.issued |
2017-02-21 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/39612 |
en |
dc.relation.ispartof |
Clinical Haematology Academic Teaching |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.title |
Megakaryocyte biology, megakaryocyte cancer genetics and implications for therapy development |
en |
dc.type |
Presentation |
en |
dc.rights.holder |
Copyright: The author |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Invited |
en |
pubs.elements-id |
663485 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
Medical Sciences |
en |
pubs.org-id |
Molecular Medicine |
en |
pubs.record-created-at-source-date |
2017-09-11 |
en |